LENSAR Inc (LNSR) Stock Ticker
LNSR right now
Market factors today
Unlock the full LNSR picture
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
LNSR stock facts
| Ticker symbol | LNSR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $85.0M |
| CEO | Nicholas T. Curtis |
| Employees | 150 |
| Headquarters | Orlando, FL, US |
| IPO date | 2020-10-02 |
| Website | www.lensar.com |
What you can see for LNSR on Tickr
Live LNSR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LNSR report.
Rankings
FAQ
What is the ticker symbol for LENSAR Inc?
The ticker symbol for LENSAR Inc is LNSR, listed on the NASDAQ.
What is LNSR?
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies…